D. Ihde

发表

myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

A. Gazdar, B. Johnson, J. Brennan, 1992, Journal of the National Cancer Institute. Monographs.

Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer.

A. Gazdar, D. Ihde, B. Ghosh, 1990, Annals of internal medicine.

myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens.

R. Makuch, A. Gazdar, E. Russell, 1991, Cancer research.

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.

E. Sausville, R. Makuch, J. Minna, 1988, Annals of internal medicine.

Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.

R. Makuch, A. Gazdar, P. Bunn, 1980, Journal of the National Cancer Institute.

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.

D. Longo, P. Bunn, K. Foon, 1984, Annals of internal medicine.

Small Cell Bronchogenic Carcinoma: A Review of Therapeutic Results

P. Bunn, D. Ihde, 1981 .

Smoking Cessation after Successful Treatment of Small-Cell Lung Cancer Is Associated with Fewer Smoking-related Second Primary Cancers

M. Tucker, D. Venzon, D. Ihde, 1993, Annals of Internal Medicine.

Recent developments in the treatment of lung cancer.

A. Lin, D. Ihde, 1992, JAMA.

Therapy of small cell lung cancer: a perspective on two decades of clinical research.

D. Ihde, E. Seifter, 1988, Seminars in oncology.

Results of therapeutic cranial irradiation in small cell lung cancer.

J. Carmichael, P. Bunn, E. Glatstein, 1988, International journal of radiation oncology, biology, physics.

Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy.

R. Fisher, D. Longo, P. Pizzo, 1986, Annals of internal medicine.

Chemotherapy rather than demeclocycline for inappropriate secretion of antidiuretic hormone.

J. Minna, P. Bunn, D. Ihde, 1978, The New England journal of medicine.

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

R. Makuch, J. Minna, J. Minna, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival.

A. Gazdar, D. Venzon, D. Ihde, 1990, European journal of cancer.

Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.

D. Ihde, R. Newman, J. Eddy, 1983, Radiology.

Is there a place for classical adjuvant treatment?

D. Ihde, 1994, Lung cancer.

Current status of therapy for small cell carcinoma of the lung

D. Ihde, 1984, Cancer.

Atrial Natriuretic Factor and Arginine Vasopressin Production in T\imor Cell Lines from Patients with Lung Cancer and Their Relationship to Serum Sodium1

S. Steinberg, B. Johnson, D. Ihde, 2006 .

Herpes zoster and small cell bronchogenic carcinoma.

J. Minna, P. Bunn, D. Ihde, 1980, The American journal of medicine.

Response to thoracic radiotherapy in patients with small cell carcinoma of the lung after failure of combination chemotherapy.

J. Minna, P. Bunn, D. Ihde, 1979, Radiology.

Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.

V. Devita, D. Ihde, G. Canellos, 1976 .

Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.

V. Devita, D. Ihde, R. Young, 1976, Blood.

Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.

E. Jaffe, P. Duffey, D. Longo, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Screening for Lung Cancer Has No Proven Utility-Reply

A. Lin, D. Ihde, 1992 .

Postoperative mediastinal radiation for cancer of the lung.

M. Gail, J. Minna, J. Cooper, 1987, The New England journal of medicine.

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

S. Steinberg, B. Kramer, A. Gazdar, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Staging and prognostic factors in small cell lung cancer: a consensus report

R. Ginsberg, P. Houtte, F. Hirsch, 1989 .

Small Cell Lung Cancer: State-of-the-Art Therapy 1994

D. Ihde, 1995 .

Induction therapy for NSCLC: a consensus report

R. Mirimanoff, R. Ginsberg, A. Gregor, 1991 .

Small-cell lung cancer: treatment progress and prospects.

D. Ihde, R. Clark, Romnee S. Clark, 1998, Oncology.

A COMPARISON OF COMPUTED TOMOGRAPHY AND RADIONUCLIDE SCANNING FOR DETECTION OF BRAIN METASTASES IN SMALL CELL LUNG CANCER

R. Makuch, P. Bunn, E. Glatstein, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

S. Steinberg, A. Gazdar, A. Gazdar, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-small cell lung cancer. Part I: Biology, diagnosis, and staging.

J. Minna, D. Ihde, D C Ihde, 1991, Current problems in cancer.

Chemotherapy combined with chest irradiation for locally advanced non-small cell lung cancer.

D. Ihde, 1991, Annals of internal medicine.

Erythroleukemia and other hematologic complications of intensive therapy in long‐term survivors of small cell lung cancer

J. Minna, J. Whang‐Peng, P. Bunn, 1982 .

Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse.

J. Minna, P. Bunn, D. Ihde, 1978, Chest.

Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer.

R. Makuch, J. Minna, P. Bunn, 1986, The American journal of medicine.

Lung cancer: scalpels, beams, drugs, and probes.

J. Minna, E. Glatstein, D. Ihde, 1986, The New England journal of medicine.

Small-cell carcinoma of lung: reinduction therapy after late relapse.

P. Bunn, G. Batist, D. Carney, 1983, Annals of internal medicine.

Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients.

R. Souhami, R. Arriagada, J. Pignon, 1994, Anticancer research.

Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up.

R. Makuch, J. Minna, J. Whang‐Peng, 1985, Annals of internal medicine.

Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.

R. Makuch, J. Minna, P. Bunn, 1979, Cancer treatment reports.

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.

R. Abrams, R. Makuch, P. Bunn, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small cell lung cancer 1973-1983: early progress and recent obstacles.

J. Minna, P. Bunn, D. Carney, 1984, International journal of radiation oncology, biology, physics.

Advances in small cell bronchogenic carcinoma.

J. Minna, P. Bunn, D. Ihde, 1977, Cancer treatment reports.

National Institutes of Health Consensus Development Conference Statement on Cervical Cancer

W. H. Hall, P. Grigsby, B. Kramer, 1997 .

Different Combination Chemotherapy Regimens Lines from Patients with Small Cell Lung Cancer Treated with Family DNA Amplification in 107 Tumors and Tumor Cell myc

A. Gazdar, E. Russell, D. Ihde, 2006 .

Prophylactic cranial irradiation: current controversies

D. Ihde, 1993 .

Obesity and therapy-related toxicity in patients treated for small-cell lung cancer.

S. Steinberg, B. Johnson, D. Ihde, 1995, Journal of the National Cancer Institute.

Treatment of diffuse large cell non-Hodgkin’s lymphomas

R. Fisher, D. Longo, V. Devita, 1985 .

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.

E. Jaffe, R. Fisher, P. Duffey, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.

M. Zweig, D. Ihde, 1985, Cancer research.

Abdominal CT in the evaluation of small cell carcinoma of the lung.

D. Ihde, N. Dunnick, A. Johnston-Early, 1979, AJR. American journal of roentgenology.

Abdominal computed tomography in small cell lung cancer: Assessment of extent of disease and response to therapy

J. Minna, P. Bunn, Martin H. Cohen, 1982 .

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer

S. Steinberg, A. Gazdar, E. Russell, 1996, Journal of cellular biochemistry. Supplement.

A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer.

R. Makuch, E. Glatstein, D. Ihde, 1984 .

Small cell lung cancer.

A. Gregor, P. Rocmans, P. Postmus, 1997, Lung cancer.

Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital.

S. Winawer, J. Fortner, P. Sherlock, 1974, The American journal of medicine.

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

J. Minna, D. Ihde, M. Cohen, 1977, Cancer treatment reports.

Combination chemotherapy with doxorubicin and mitomycin C in non small cell bronchogenic carcinoma: Severe pulmonary toxicity from q 3 weekly mitomycin C

J. Minna, P. Bunn, L. Doyle, 1984, American journal of clinical oncology.

Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.

J. Minna, A. Gazdar, P. Bunn, 1979, Cancer treatment reports.

Second primary malignancies in small-cell lung cancer: a major consequence of modest success.

M. Tucker, D. Ihde, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computed Tomography in Primary Hepatocellular Carcinoma

J. Doppman, D. Ihde, N. Dunnick, 1980, Journal of computer assisted tomography.

Carcinomatous Leptomeningitis in Small Cell Lung Cancer: A Clinicopathologic Review of the National Cancer Institute Experience

R. Makuch, P. Bunn, S. Rosen, 1982, Medicine.

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.

E. Kohn, E. Sausville, D. Longo, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis

J. Minna, P. Bunn, D. Ihde, 1979 .

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

W. M. Linehan, W. Linehan, Y. Ostchega, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.

R. Schilsky, D. Ihde, R. Young, 1982, Cancer research.

Possible enhancement of vincristine neuropathy by VP‐16

J. Minna, P. Bunn, D. Ihde, 1982, Cancer.

The role of radiation therapy in the treatment of small cell lung cancer

R. Makuch, J. Minna, P. Bunn, 1985, Cancer.

Evaluation of response to chemotherapy with fiberoptic bronchoscopy in non‐small cell lung cancer

J. Minna, P. Bunn, J. Minna, 1980, Cancer.

Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.

J. Minna, D. Ihde, M. Matthews, 1976, Cancer treatment reports.

Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung.

J. Minna, P. Bunn, D. Carney, 1982, Cancer treatment reports.

Phase II trial of cisplatin in small cell carcinoma of the lung.

J. Minna, P. Bunn, D. Ihde, 1981, Cancer treatment reports.

Treatment of small cell undifferentiated carcinoma of the lung: update of recent results.

J. Minna, N. Martini, R. Weiss, 1980, Cancer treatment reports.

Adriamycin therapy in American patients with hepatocellular carcinoma.

J. Minna, D. Ihde, R. Kane, 1977, Cancer treatment reports.

Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma.

J. Minna, D. Ihde, M. Cohen, 1977, Cancer treatment reports.

Clinical spectrum of infection due to Bacillus species.

D. Armstrong, D. Ihde, D. Armstrong, 1973, The American journal of medicine.

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin

J. Minna, A. Gazdar, H. Pass, 1993 .

National Institutes of Health consensus development conference on oral complications of cancer therapies : diagnosis, prevention and treatment

D. Ihde, 1990 .

The evolving role of systemic therapy in carcinoma of the lung.

E. Vokes, D. Haraf, D. Ihde, 1992, Seminars in oncology.

myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

R. Makuch, J. Minna, A. Gazdar, 1987, The Journal of clinical investigation.

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

E. Jaffe, R. Fisher, P. Duffey, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High‐dose methotrexate with leucovorin rescue in patients with unresectable non‐small cell carcinoma of the lung

J. Minna, P. Bunn, J. Minna, 1983, Cancer.

Growth of lung cancer colonies from bronchoscopy washings

R. Makuch, D. V. Von Hoff, M. Layard, 1981, Cancer.

Cardiac candidiasis in cancer patients

W. Roberts, H. Brereton, A. Levine, 1978, Cancer.

Recombinant interferon alfa‐2a, an active agent in advanced cutaneous t‐cell lymphomas

P. Bunn, K. Foon, D. Ihde, 1987, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Hepatic involvement in the cutaneous T‐cell lymphomas. Results of percutaneous biopsy and peritoneoscopy

J. Minna, A. Gazdar, P. Bunn, 1980, Cancer.

Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.

G. Giaccone, A. Gazdar, J. Mulshine, 1992, Journal of the National Cancer Institute. Monographs.

A Phase II Trial of Carboplatin (CBDCA) in Small‐Cell and Non‐Small‐Cell Lung Cancer with Correlation to In Vitro Analysis of Cytotoxicity

E. Dmitrovsky, A. Gazdar, J. Mulshine, 1990, American journal of clinical oncology.

Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy.

J. Minna, A. Gazdar, P. Bunn, 1981, Journal of the National Cancer Institute.

Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy.

J. Minna, P. Bunn, D. Ihde, 1982, Cancer.

Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids)

V. Devita, D. Ihde, Vincent T. Devita, 1975, Cancer.

NCI‐navy medical oncology branch cell line data base

J. Minna, A. Gazdar, D. Carbone, 1996, Journal of cellular biochemistry. Supplement.

Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

R. Shoemaker, A. Gazdar, J. Mulshine, 1993, Investigational New Drugs.

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

S. Steinberg, E. Sausville, F. Kaye, 1989, The New England journal of medicine.

Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination.

J. Minna, A. Gazdar, J. Whang‐Peng, 1980, Annals of internal medicine.

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

S. Steinberg, I. Linnoila, F. Foss, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of recombinant interferon alfa‐2a in the therapy of cutaneous t‐cell lymphomas

P. Bunn, K. Foon, D. Ihde, 1986, Cancer.

SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER

J. Minna, A. Gazdar, P. Bunn, 1982, The Lancet.

Clinical trials in primary hepatocellular carcinoma: current status and future directions.

D. Ihde, M. Friedman, S. Nerenstone, 1988, Cancer treatment reviews.

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

S. Steinberg, J. Mulshine, B. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnosis and significance of liver metastases in small cell carcinoma of the lung.

R. Makuch, J. Minna, J. Mulshine, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion

G. Batist, J. Grygiel, R. Fine, 2004, Investigational New Drugs.

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.

R. Makuch, J. Minna, P. Bunn, 1979, JAMA.

CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival

J. Minna, A. Gazdar, P. Bunn, 1979, Cancer.

Report of the Seventh International Symposium of the Foundation for Promotion of Cancer Research: fundamental and clinical research in lung cancer.

J. Yokota, A. Gazdar, N. Saijo, 1994, Japanese journal of clinical oncology.

Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer.

J. Battey, J. Minna, A. Gazdar, 1986, Cold Spring Harbor Symposia on Quantitative Biology.

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.

P. Bunn, D. Ihde, P. Radice, 1979, Cancer treatment reports.

The clinical behavior of „mixed”︁ small cell/large cell bronchogenic carcinoma compared to „pure”︁ small cell subtypes

R. Makuch, J. Minna, A. Gazdar, 1982, Cancer.

Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.

E. Dmitrovsky, E. Sausville, R. Makuch, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer.

R. Makuch, B. Johnson, M. Krehbiel, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MDR1 gene expression in lung cancer.

I. Pastan, M. Gottesman, A. Gazdar, 1989, Journal of the National Cancer Institute.

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

J P Pignon, M. Tattersall, R. Souhami, 1992, The New England journal of medicine.

Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors.

W. Hayes, B. Johnson, E. Glatstein, 1990, Journal of Clinical Oncology.

Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.

S. Steinberg, A. Gazdar, E. Russell, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic implications of evaluation for lymph node involvement by T- cell antigen receptor gene rearrangement in mycosis fungoides

S. Steinberg, E. Sausville, E. Sausville, 1992 .

Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides.

S. Steinberg, E. Sausville, A. Fischmann, 1992, Blood.

Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients.

V. Devita, D. Ihde, G. Canellos, 2020, Annals of internal medicine.

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

E. Jaffe, P. Duffey, D. Longo, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of relationship between in vitro tumor cell growth and prognosis in extensive-stage small-cell lung cancer.

S. Steinberg, A. Gazdar, E. Russell, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Staging and prognostic factors in small cell carcinoma of the lung.

D. Ettinger, M. Ro̸rth, R. Gralla, 1983, Cancer treatment reports.

The effect of combined modality therapy on local control and survival.

V. Devita, S. Rosenberg, D. Ihde, 1986, International journal of radiation oncology, biology, physics.

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.

W. Wilson, E. Jaffe, R. Wittes, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.

E. Jaffe, D. Longo, V. Devita, 1988, Seminars in hematology.

Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.

R. Makuch, J. Minna, P. Bunn, 1981, Cancer treatment reports.

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non‐small cell lung cancer and small cell lung cancer

S. Steinberg, J. Minna, A. Gazdar, 1996, Journal of cellular biochemistry. Supplement.

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.

S. Steinberg, J. Minna, A. Gazdar, 1993, Cancer research.

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

S. Steinberg, J. Minna, A. Gazdar, 1990, Journal of the National Cancer Institute.

Non-small cell lung cancer. Part II: Treatment.

J. Minna, D. Ihde, 1991, Current problems in cancer.

Chemotherapy of Lung Cancer

D. Ihde, D C Ihde, 1992 .

Female patients with small cell lung cancer live longer than male patients.

S. Steinberg, B. Johnson, D. Ihde, 1988, The American journal of medicine.

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.

S. Steinberg, J. Mulshine, B. Johnson, 1993, Cancer research.

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

I. Linnoila, F. Foss, J. Breneman, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.

R. Makuch, J. Minna, N. Javadpour, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.

E. Sausville, R. Makuch, J. Minna, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Elevated serum creatine kinase BB levels in patients with small cell lung cancer.

R. Makuch, M. Zweig, A. Gazdar, 1984, Cancer research.

Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy.

R. Makuch, J. Minna, P. Bunn, 1983, The American journal of medicine.

Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response.

R. Makuch, J. Minna, P. Bunn, 1983, The American journal of medicine.

Smoking abstinence and small cell lung cancer survival. An association.

R. Makuch, J. Minna, P. Bunn, 1980, JAMA.

Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity.

V. Devita, D. Ihde, R. S. Francis, 1975, Cancer chemotherapy reports.

Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs.

D. Venzon, B. Johnson, D. Ihde, 1993, Archives of internal medicine.

Growth rates of small cell bronchogenic carcinomas

J. Minna, P. Bunn, S. Shackney, 1978, Cancer.

Small cell carcinoma of the lung: clinical and biologic aspects.

D. Ihde, J. Viallet, 1991, Critical reviews in oncology/hematology.

Calcitonin elevation in small cell lung cancer without ectopic production.

D. Venzon, M. Kelley, B. Johnson, 1994, American journal of respiratory and critical care medicine.

Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.

R. Makuch, J. Minna, P. Bunn, 1981, The American review of respiratory disease.

The role of recombinant interferon alfa‐2a in the therapy of cutaneous t‐cell lymphomas

P. Bunn, K. Foon, D. Ihde, 1986, Cancer.

Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.

P. Bunn, G. Batist, K. Cowan, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of cutaneous T-cell lymphomas with biologic response modifiers: Recombinant leukocyte A interferon and T101 monoclonal antibody

S. Larson, J. Minna, D. Longo, 1985 .

Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors

R. Donehower, D. Ihde, W. Tester, 1982, Cancer Chemotherapy and Pharmacology.

Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer

R. Makuch, J. Minna, P. Bunn, 1983, Cancer.

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.

P. Okunieff, D. Venzon, B. Johnson, 1997, Mayo Clinic proceedings.

Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.

J. Minna, P. Bunn, D. Ihde, 1981, AJR. American journal of roentgenology.

Computed tomography of the abdomen and pelvis: documentation of tumor response and progression in disseminated prostate cancer.

D. Ihde, R. Newman, J. Eddy, 1986, Medical and pediatric oncology.

Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer.

R. Makuch, J. Minna, A. Gazdar, 1982, Bulletin du cancer.

Effective treatment of hormonally‐unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide methods of documenting tumor response and progression

J. Minna, P. Bunn, D. Ihde, 1980, Cancer.

Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer.

J. Goldie, R. Souhami, R. Arriagada, 1988, Antibiotics and chemotherapy.

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.

R. Makuch, D. Ihde, J. Eddy, 1985, The American journal of medicine.

Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.

M. Boyd, D. Ihde, R. Young, 1981, Cancer treatment reports.

Concordant expression of gastrin releasing peptide (GRP) and GRP gene associated peptides (GGAPs) in primary and metastatic human small cell lung cancers (SCLCs): An immunohistochemical analysis

G. Patterson, I. Linnoila, S. Jensen, 1987, Regulatory Peptides.

Management of high risk patients with advanced testis cancer: National Cancer Institute approach.

W. M. Linehan, R. Ozols, D. Ihde, 1988, Seminars in oncology.

Perirectal infections in patients with small cell lung cancer.

J. Minna, P. Bunn, D. Ihde, 1981, JAMA.

Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.

J. Minna, P. Bunn, D. Carney, 1984, Cancer treatment reports.

Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.

D. Ihde, J. Viallet, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer

S. Steinberg, A. Gazdar, E. Russell, 1996, Journal of cellular biochemistry. Supplement.

Current status of therapy for small cell carcinoma of the lung

D. Ihde, 1984, Cancer.

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

S. Steinberg, J. Minna, A. Gazdar, 1990, Journal of the National Cancer Institute.

Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial.

R. Makuch, J. Minna, P. Bunn, 1987, Annals of internal medicine.

Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.

J. Minna, P. Bunn, D. Ihde, 1983, American Journal of Clinical Oncology.

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.

J. Herndon, E. Vokes, Mark R. Green, 2000, Lung cancer.

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer.

J. Minna, J. Whang‐Peng, P. Bunn, 1982, Cancer.

description, and influence on chemotherapeutic toxicity and prognosis Bone marrow metastases in small cell carcinoma of the lung: frequency,

P. Bunn, J. Minna, D. Ihde, 2011 .

Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis.

P. Bunn, J. Minna, D. Ihde, 1979, Blood.

The role of radiation therapy in the treatment of small cell lung cancer

R. Makuch, J. Minna, P. Bunn, 1985, Cancer.

"Salvage" radiation therapy for intrathoracic small cell carcinoma of the lung progressing on combination chemotherapy.

A. Lichter, D. Ihde, W. Tester, 1983, Cancer treatment reports.

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.

B. Kramer, J. Minna, A. Gazdar, 1994, Lung cancer.

Practical issues in the management of the patient with small cell lung cancer.

R. Govindan, D. Ihde, 1997, Chest surgery clinics of North America.